FDA posts photos of Indian drugmaking facility cited in warning letternews2026-03-23T17:13:29+00:00March 23rd, 2026|Endpoints News|
WuXi AppTec’s bet on the US pays off as revenues dip elsewherenews2026-03-23T15:24:18+00:00March 23rd, 2026|Endpoints News|
Former Acorda CEO Ron Cohen emerges at Parkinson’s cell therapy biotech Oryonnews2026-03-23T15:16:14+00:00March 23rd, 2026|Endpoints News|
CEO and C-suite are out in battle for control of Aurinianews2026-03-23T14:11:04+00:00March 23rd, 2026|Endpoints News|
Dizal’s first-line lung cancer data; Sanofi expands in Chinanews2026-03-23T14:01:38+00:00March 23rd, 2026|Endpoints News|
Apogee shares positive mid-stage maintenance data for eczema drug that could challenge Dupixent, Ebglyssnews2026-03-23T11:08:26+00:00March 23rd, 2026|Endpoints News|
Arikayce could become Insmed’s second blockbuster following late-stage win in lung infectionnews2026-03-23T11:01:00+00:00March 23rd, 2026|Endpoints News|
Sanofi extends $180M to California T cell engager startup Kalinews2026-03-23T11:00:42+00:00March 23rd, 2026|Endpoints News|
Pfizer’s Lyme disease vaccine trial hampered by lack of casesnews2026-03-23T10:45:45+00:00March 23rd, 2026|Endpoints News|
Roche, Nvidia’s ‘AI Factory’; Industry looks to soften MFN impact; Structure’s oral GLP-1 data; and morenews2026-03-21T10:00:30+00:00March 21st, 2026|Endpoints News|
